“↘공효일엔↗삼각지오피〔 YEOTOP1.COM 〕 삼각지오피ⅱ삼각지휴게텔く삼각지키스방✆삼각지출장ⅳ삼각지OP☲삼각지립카페”的搜索结果，显示 201-210 项，共有 9196 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   （仅限仍在招募的研究）. 按院区、状态和其他条件筛选该研究列表。 A Study to Evaluate MRTX849 in Patients with Advanced Solid Tumors with ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   以下为当前的临床试验。 469 研究肿瘤科（内科） （仅限仍在招募的研究）. 按院区、状态和其他条件 ...

3. 肾病和高血压- 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate whether or not semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 ...

4. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   A Phase 1b/2, open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, ...

5. 神经科- 临床试验- 妙佑医疗国际

   117 研究神经科（仅限仍在招募的研究）. 按院区、状态和其他条件筛选该研究列表。 Arizona Alzheimer's Disease Research Center (ADRC-001).

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL). Rochester, Minn. The purpose of ths study is to find out more about ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this combination ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   （仅限仍在招募的研究）. 按院区、状态和其他条件筛选该研究列表。 A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...